Bioassay for Cyclophosphamide in Mice
Author Information
Author(s): A.C. Begg, K.A. Smith
Primary Institution: Gray Laboratory of the Cancer Research Campaign, Mount Vernon Hospital
Hypothesis
Can a bioassay be developed to detect and quantify cytotoxic metabolites of cyclophosphamide in blood, lung, and tumors of mice?
Conclusion
The developed bioassay effectively detects cytotoxic metabolites of cyclophosphamide in various tissues, providing insights into their pharmacokinetics.
Supporting Evidence
- The bioassay can detect cytotoxic metabolites in blood after doses as low as 10 mg/kg.
- The half-life of metabolites in blood decreased from 14 to 9 minutes after a 400 mg/kg dose.
- Maximum metabolite levels in tumors occurred approximately 45 minutes after injection.
Takeaway
Researchers created a test to see how much of a cancer drug is in the blood and tumors of mice, helping to understand how the drug works.
Methodology
Mice were injected with cyclophosphamide, and blood, lung, and tumor samples were taken to measure cytotoxic metabolites using a bioassay with Chinese Hamster V79 cells.
Limitations
The study does not prove that the extraction fraction of metabolites is the same across different tumor types.
Participant Demographics
Mice of two strains (CBA/HtGyfBSVS and WHT/GyfBSVS) were used in the study.
Want to read the original?
Access the complete publication on the publisher's website